Products

What will AGI do for Almasilate?

This classification denotes an aluminum silicates and antacid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OZQ8O62H53. European Medicines Agency schedules Almasilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05344MIG. Almasilate generally arises in the molecular formula 2AL.MG.8O.2SI.H2O. The term ALMASILATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, no. 10 1980, list 20.) ALMASILATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule almasilate under HS 28421000 and SITC 52389. As of Q4 2014, ALMASILATE remains the US FDA Preferred Term for this commodity. SMILES: O.O[Si](=O)O.O[Si](=O)O.[Mg+2].[Al+3].[Al+3].

How AGI delivers it

Four ways AGI delivers for Almasilate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Almasilate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Almasilate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Almasilate connects

measured by

  • Acid-Neutralizing Capacitymodel
  • Assay Puritymodel
  • Loss On Dryingmodel
  • Silica Contentmodel